Immune cells and cytokine networks

Immune cells and cytokine networks refer to the complex, integrated system of specialized cells and signaling proteins that coordinate the body's defense against pathogens and maintain tissue homeostasis. This network involves a diverse array of cell types, including T cells, B cells, macrophages, and dendritic cells, which communicate via cytokines such as interleukins, interferons, and tumor necrosis factors (StatPearls, 2023). While essential for health, dysregulation of these networks is a primary driver of autoimmune diseases, chronic inflammation, and the progression of various cancers (Nature Reviews Immunology, 2018). Pharmacological intervention typically does not target the network as a whole but rather focuses on specific nodes, such as individual cytokines or their receptors, to restore balance. Common therapeutic strategies include the use of monoclonal antibodies to neutralize pro-inflammatory signals or small molecules to inhibit intracellular signaling pathways like JAK-STAT (PubMed, 2021). These interventions are critical in treating conditions like rheumatoid arthritis, psoriasis, and inflammatory bowel disease. However, modulating these networks carries risks, such as increased susceptibility to infections due to dampened immune surveillance.

Other names

Immune systemCytokine signaling networkInflammatory cascadeCytokine milieuImmune-cytokine axis

Therapeutic agents modulate the network by neutralizing specific cytokines (e.g., TNF-alpha, IL-6, IL-17), blocking their respective receptors, depleting specific immune cell populations (e.g., B cells), or inhibiting intracellular signaling cascades such as the JAK-STAT pathway to restore immunological balance.